BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.7248
+0.0044 (0.61%)
At close: Aug 13, 2025, 4:00 PM
0.7293
+0.0045 (0.62%)
After-hours: Aug 13, 2025, 6:57 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,214,666
Market Cap
12.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCTX News
- 11 hours ago - BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer - GlobeNewsWire
- 7 days ago - BriaCell Announces Proposed Effective Date of Share Consolidation - GlobeNewsWire
- 13 days ago - BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - GlobeNewsWire
- 14 days ago - BriaCell Awarded New Zealand Patent for its Whole Cell Technology - GlobeNewsWire
- 15 days ago - BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents - GlobeNewsWire
- 19 days ago - BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025 - GlobeNewsWire
- 4 weeks ago - BriaCell Therapeutics Announces Closing of $15 million Public Offering - GlobeNewsWire
- 4 weeks ago - BriaCell Therapeutics Announces Pricing of $15 million Public Offering - GlobeNewsWire